Pregled bibliografske jedinice broj: 1140838
Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review
Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review // Clinical and Translational Imaging, 9 (2021), 3; 233-240 doi:10.1007/s40336-021-00419-y (međunarodna recenzija, pregledni rad, ostalo)
CROSBI ID: 1140838 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review
Autori
Giovanella, Luca ; Ruggeri, Rosaria M. ; Petranović Ovčariček, Petra ; Campenni, Alfredo ; Treglia, Giorgio ; Deandreis, Desiree
Izvornik
Clinical and Translational Imaging (2281-5872) 9
(2021), 3;
233-240
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, ostalo
Ključne riječi
COVID-19 ; SARS-CoV-2 ; thyroid ; TSH ; thyroid dysfunction ; systematic review
Sažetak
Purpose Currently, there is an increasing interest regarding the impact of COVID-19 on the thyroid function. As several recent reports have described the onset of thyroid dysfunction in patients diagnosed with COVID-19, we performed a systematic review to assess the prevalence of thyroid dysfunction in patients with COVID-19 as this information could be clinically relevant for the management of these patients. Methods A comprehensive computer literature search using PubMed/Medline and Cochrane databases was performed until November 14, 2020 to search original articles evaluating thyroid dysfunction in COVID-19 patients. Information about thyroid dysfunction assessed by thyroid function test was retrieved by the eligible articles. Qualitative analysis (systematic review) only was performed whether a significant heterogeneity of data was detected. Results Seven studies including 1237 patients with COVID- 19 were included. A significant heterogeneity across the studies was found. Most COVID-19 patients were euthyroid with TSH levels in the normal range (from 44 to 94% of the COVID-19 patients assessed in the included studies). The prevalence of thyroid dysfunction in COVID-19 patients (defined as abnormal thyroid function tests) largely varies among the included studies between 13 and 64% of COVID-19 patients as well as clinical presentation. A positive correlation between thyroid dysfunction and clinical severity of COVID-19 was reported. Conclusion Literature data show that thyroid dysfunction is present in a significant percentage of patients with COVID-19. Assessment of thyroid function may be considered in symptomatic COVID-19 patients to have a baseline before introducing thyroid- interfering drugs and those requiring high- intensity care. Further, well-designed studies are needed to better elucidate the impact of COVID-19 on thyroid function and inform thyroid function testing and thyroid dysfunction management in COVID-19 patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus